Takeda Pharmaceutical Company Limited reports that its global oncology business unit, headquartered in Cambridge, Massachusetts, will be called Takeda Oncology. Takeda is retiring the Millennium: The Takeda Oncology Company brand, and replacing it with Takeda Oncology to reflect the new global oncology business unit.

Comprised of Takeda's global oncology commercial operations, the Oncology Business Unit remains aligned with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit, and Takeda's Oncology Drug Discovery Unit.

Takeda acquired Millennium Pharmaceuticals in 2008 and subsequently used the name in its branding.

Source: Takeda Pharmaceutical